Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients with Pre-Treated Advanced Gastric Cancer November 28, 2017October 21, 2019 by / Share This.....LinkedinTwitterFacebookGoogleEmailDownload PDF Related News: Thermo Fisher Scientific & Pfizer Partner to…Mass spectrometry technology contributed to the…Roche announces U.S. collaboration with Pfizer to…Ad hoc announcement pursuant to Art. 53 LR Roche…Mass spectrometry technology contributed to a…New Roche data for Evrysdi show improved motor…Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)
